Catherine Ingham is a Senior Scientist at AstraZeneca, having transitioned to this role in 2025 after serving as a Senior Scientist at Revvity from 2015 to 2025. Previously, Catherine worked as a Research Associate at Fahy Gurteen UK Limited from 2012 to 2015 and completed a PhD in Biotechnology at the University of Manchester between 2008 and 2012. Catherine also gained experience during an industrial placement at Pfizer in 2006-2007 and held a CASE award position at UCB Pharma while pursuing their doctoral studies. Catherine earned a BSc in Molecular and Cellular Biology from the University of Bath, completed in 2008.
This person is not in the org chart
This person is not in any teams
This person is not in any offices